4 recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia SHR4640 ï¼›Febuxostat, SHR4640 ; Febuxostat, SHR4640 - Primary Gout and Hyperuricemia | Phase 2 | Recruiting | Jiangsu HengRui Medicine Co., Ltd. | 340 | 2026-02-09 | 2026-04-07 |
| A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE) PRX-115, Methotrexate (MTX), PRX-115 placebo - Gout | Phase 2 | Recruiting | Protalix | 150 | 2025-12-22 | 2026-09-29 |
| A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease IG3018, Placebo matching IG3018 - Hyperuricemia, Hypouricemia, Renal | Phase 1 / Phase 2 | Recruiting | Intelligem Therapeutics Australia Pty Ltd. | 60 | 2024-11-12 | 2026-02-03 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack | Phase 2 / Phase 3 | Recruiting | Olatec Therapeutics, Inc. | 300 | 2023-01-06 | 2026-03-11 |
Gout (2) · Arthralgia (1) · Arthritis (1) · Arthritis, Gouty (1) · Inflammation (1) · Renal Insufficiency, Chronic (1) · Renal hypouricemia (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Crystal Arthropathies (2) · Genetic Diseases, Inborn (2) · Joint Diseases (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Purine-Pyrimidine Metabolism, Inborn Errors (2) · Rheumatic Diseases (2) · Arthritis (1) · Chronic Disease (1) · Disease Attributes (1)
Febuxostat (1) · Methotrexate (1) · dapansutrile (1) · ruzinurad (1)
Intelligem Therapeutics Australia Pty Ltd. (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Olatec Therapeutics, Inc. (1) · Protalix (1)
Israel (2) · United States (2) · Australia (1) · China (1) · France (1) · Georgia (1) · Netherlands (1) · Spain (1) · Taiwan (1)